Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:8991 |
| Name | cervix uteri carcinoma in situ |
| Definition | An uterus carcinoma in situ that is located_in the uterine cervix. |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Path | disease disease of cellular proliferation pre-malignant neoplasm in situ carcinoma uterus carcinoma in situ cervix uteri carcinoma in situ |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04712851 | Phase II | Pembrolizumab | Pembrolizumab for the Treatment of High-Grade Vulvar, Vaginal, or Cervical Intraepithelial Neoplasia | Recruiting | USA | 0 |